Editor's Note
The Food and Drug Administration (FDA) on January 26 updated the Class I recall of certain Trilogy Evo ventilators and repair kits for Trilogy Evo muffler assembly, which are manufactured by Philips Respironics.
According to the update, the FDA has asked the company to have an independent laboratory determine if an incorrect silicone-based foam used to repair and replace the ventilators poses a risk to patient safety.
The ventilators were previously recalled in June 2021 because of the same foam risk.
Distribution dates were April 15, 2021, to May 24, 2021. There have been no reported injuries or deaths to date.
Read More >>Healthcare facilities face challenges in the recall process of tissue,…
Situational awareness is the perception of events occurring around a…
The medical device industry aims to create valuable innovations that…